Want to see GB:EMVC full AI Analyst Report?
EMVC Stock Chart & Stats
60.50 p
1.90 p(3.52%)
At close: 4:00 PM EST
60.50 p
1.90 p(3.52%)
Day’s Range― - ―
52-Week Range40.00 p - 62.00 p
Previous CloseN/A
Volume700.00
Average Volume (3M)31.99K
Market Cap
£14.40M
Enterprise Value16.35M
Total Cash (Recent Filing)£511.00K
Total Debt (Recent Filing)£2.60M
Price to Earnings (P/E)―
Beta0.59
Next Earnings
Sep 24, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding27,967,531
10 Day Avg. Volume35,929
30 Day Avg. Volume31,987
Financial Highlights & Ratios
PEG Ratio5.74
Price to Book (P/B)1.04
Price to Sales (P/S)5.52
P/FCF Ratio-12.43
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.03
Revenue Forecast (FY)£3.43M
Bulls Say, Bears Say
Bulls Say
Improving Revenue GrowthSustained mid‑teens to low‑20% revenue growth off a small base indicates increasing market traction for NetScientific’s portfolio and services. If continued, this growth can drive operating leverage and reduce reliance on financing, supporting a durable path toward breakeven and value realization.
High Gross Margins On RevenueConsistently high gross margins imply the core activities or realized investments have low direct costs, creating scope for scalable profitability as revenues grow. High gross margins provide structural room to absorb SG&A while enabling potential rapid margin expansion when top line scales.
Conservative Historical LeverageA strong equity base and historically low debt provide financial flexibility to support portfolio development and absorb operating deficits. This structural strength reduces immediate insolvency risk and gives management time to execute exits or capital raises without urgent distress.
Bears Say
Persistent Negative Cash FlowOngoing negative operating and free cash flow is a fundamental weakness: the business is not self‑funding and must rely on external capital or balance sheet resources. Over months this raises execution risk, may force dilutive financings, and constrains the company’s ability to support portfolio companies.
Sustained Operating LossesRepeated deep operating losses show the cost base has remained too high relative to revenue for multiple years. Until structural cost control or higher recurring revenue is achieved, profitability prospects remain uncertain, limiting free cash flow generation and long‑term resilience.
Rising Debt And Falling EquityThe combination of increased debt and declining equity from cumulative losses weakens the balance sheet over time. This structural shift raises refinancing and liquidity risk if cash burn persists, potentially forcing asset disposals or constrained support for portfolio investments.
NetScientific News
EMVC FAQ
What was NetScientific PLC’s price range in the past 12 months?
NetScientific PLC lowest share price was 40.00 p and its highest was 62.00 p in the past 12 months.
What is NetScientific PLC’s market cap?
NetScientific PLC’s market cap is £14.40M.
When is NetScientific PLC’s upcoming earnings report date?
NetScientific PLC’s upcoming earnings report date is Sep 24, 2026 which is in 80 days.
How were NetScientific PLC’s earnings last quarter?
Currently, no data Available
Is NetScientific PLC overvalued?
According to Wall Street analysts NetScientific PLC’s price is currently Overvalued.
Does NetScientific PLC pay dividends?
NetScientific PLC does not currently pay dividends.
What is NetScientific PLC’s EPS estimate?
NetScientific PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does NetScientific PLC have?
NetScientific PLC has 27,967,531 shares outstanding.
What happened to NetScientific PLC’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of NetScientific PLC?
Currently, no hedge funds are holding shares in GB:EMVC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
NetScientific PLC
EMV Capital plc operates as a venture capital firm, primarily targeting investments across the full spectrum of early-stage funding, from seed rounds through to mid-stage and growth capital. Its investment mandate spans diverse high-growth sectors, including sustainability, life science, technology, transformative biomedical, deep tech, semiconductors, industrials, robotics, and artificial intelligence. The firm also places a strong emphasis on healthcare technologies, particularly digital health, diagnostics, and therapeutics, with a specific focus on ventures that enhance the lives and health outcomes of individuals battling chronic illnesses. Within digital health, core interests lie in data analytics, advanced wearable devices, and other related technologies. Geographically, EMV Capital seeks opportunities within developed European markets, including its home base in the United Kingdom, as well as the United States. While typical investment sizes reach up to £15 million (approximately $20.32 million), the firm retains the flexibility to commit larger sums. A strategic preference is to secure a controlling stake in key subsidiary companies, with investments primarily executed via its balance sheet. Established in 2008, EMV Capital plc operates from its headquarters in London, UK, with an additional presence in Beaconsfield.
Technical Analysis
Options Prices
Currently, No data available
---








